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We hypothesize that reduced osmolarity mixed-base (ROMB) solutions can potentially
serve as customizable treatments for acidoses, going beyond standard solutions in
clinical use, such as 1.0M sodium bicarbonate. Through in silico quantitative modeling,
by treating acidified canine blood using ROMB solutions, and by performing blood-gas
and optical microscopy measurements in vitro, we demonstrate that ROMB solutions
having a high proportion of a strong base, such as disodium carbonate or sodium
hydroxide, can be effective in reducing carbon dioxide pressure PCO2 while raising pH
and bicarbonate ion concentration without causing significant osmotic damage to red
blood cells, which can occur during rapid administration of hypertonic solutions of weak
bases. These results suggest that a ROMB solution, which is composed mostly of a
strong base, could be administered in a safe and effective manner, when compared to a
hypertonic solution of sodium bicarbonate. Because of the reduced osmolarity and the
customizable content of strong base in ROMB solutions, this approach differs from prior
approaches involving hypertonic solutions that only considered a single molar ratio of
strong to weak base. Our calculations and measurements suggest that custom-tailored
ROMB solutions merit consideration as potentially efficacious treatments for specific
types of acidosis, particularly acute metabolic acidosis and acute respiratory acidosis.
Keywords: acidosis, acidemia, acidotic, strong base, weak base, osmotic stress, spiculation, lysis
INTRODUCTION
Acute acidosis, lasting from minutes to a few days, can be respiratory or metabolic in nature
(DuBose and Hamm, 2002; Kraut and Madias, 2014). Acute respiratory acidosis occurs when the
arterial carbon dioxide pressure PCO2 rises above its normal range (≈38 mm Hg to ≈42mm Hg)
and the arterial pH falls below its normal range (from≈7.38 to≈7.42), usually a result of impaired
pulmonary function (Madias et al., 1979; Kraut and Kurtz, 2001; Kraut and Madias, 2010, 2012).
Acute metabolic acidosis occurs when serum bicarbonate concentration [HCO−3 ] falls below its
normal range (24± 1.2mEq/L), usually accompanied by a blood pH below its normal range (Kraut
and Madias, 2010). Acute metabolic acidoses are further classified according to the serum anion
gap: those in which the anion gap is unchanged (normal anion gap or hyperchloremic acidoses)
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and those in which the serum anion gap is increased (high anion
gap) (Kraut and Kurtz, 2001; Kraut and Madias, 2010). This
categorization is not only important for diagnostic purposes but
also for decisions about treatment.
Acute acidosis is associated with impaired cellular function
and an increase in morbidity and mortality (Gunnerson et al.,
2006). This cellular dysfunction is related to a decrease in pH
primarily of the interstitial and cellular compartments rather
than that of systemic blood (Kraut and Madias, 2012). Presently,
eliminating the underlying cause remains the most effective
therapy. However, if the underlying cause cannot be eliminated,
some clinicians have recommended intravenous administration
of basic aqueous solutions (i.e., “administering base”), primarily
in the form of sodium bicarbonate (NaHCO3), to improve the
acid-base milieu of tissues (Kraut and Kurtz, 2001, 2006; Kraut
and Madias, 2012, 2016; Velissaris et al., 2015). Nevertheless,
sodium bicarbonate administration has failed to improve cellular
function or to reduce mortality, even when it improves systemic
acid-base balance (Cooper et al., 1990; Forsythe and Schmidt,
2000). This has been ascribed, in part, to exacerbation of
intracellular acidosis in response to bicarbonate administration;
administered bicarbonate ions HCO−3 react with protons to
produce carbonic acid, H2CO3. The carbonic acid can then
decompose into CO2 and H2O. Cells are relatively permeable to
CO2, which rapidly penetrates them, producing an intracellular
respiratory acidosis (Levraut et al., 2001). By contrast to dissolved
CO2, HCO
−
3 must enter via channels or transporters, and its
movement into cells is significantly slower (Roos and Boron,
1981; Levraut et al., 1996; Hulikova and Swietach, 2014). This
process, although not inevitable in all circumstances in which
bicarbonate is given, appears to be most frequent if the base is
given when perfusion of tissues is low (Nielsen et al., 2002).
Other potential adverse effects of sodium bicarbonate
administration, including increases in serum osmolality when
administered as a hyperosmotic solution and sodium overload,
could further undercut its value as a clinical buffer for all causes
of acidosis. In current clinical practice, sodium bicarbonate can
be administered as a concentrated solution at 8.4%wt, equivalent
to a bicarbonate anion concentration [HCO−3 ]= 1.0M. Although
bicarbonate can also be administered after dilution or very slowly,
such administration would also reduce its capacity to raise blood
and tissue pH. As typically supplied, sodium bicarbonate solution
is very hypertonic (i.e., up to 2.0M osmolyte concentration), far
beyond the isotonic concentration of osmolyte species in human
blood of about 300mM. If administration of a very hypertonic
basic solution occurs too rapidly (e.g., via intravenous rapid
bolus injection), cells and other components in the blood could
be osmotically damaged before mixing is complete. Avoiding
such damage would be essential, particularly in seriously ill
patients. Moreover, beyond the potential for osmotic damage,
in some studies, administration of a hypertonic solution sodium
bicarbonate has been demonstrated to depress cardiovascular
function (Huseby and Gumprecht, 1981).
Since the exacerbation of intracellular pH (pHi) is presumed
to be consequence of generation of excess CO2, which during
the buffering process enters the cell more rapidly than HCO−3 ,
investigators have attempted to develop buffers that would not
generate or would even consume excess CO2. In the 1950’s,
solutions of the weak base THAM (i.e., tris-hydroxymethyl
aminomethane or “Tris,” pKa = 8.07) was introduced as an
alternative (Nahas et al., 1998). THAM is a non-carbonate
base and consumes protons by virtue of its amino group.
Moreover, it penetrates cells and therefore theoretically could
raise pHi. THAM improves cardiac contractility in individuals
with respiratory acidosis (Weber et al., 2000). However, although
THAM can raise pH, it has to be eliminated from the body
through the kidneys and therefore can create undesirable side
effects in individuals who have compromised renal function,
a common abnormality in patients who have acute metabolic
acidosis. Consequently, although THAM is approved for use in
treating acidotic patients, it is administered much less frequently
than sodium bicarbonate. Also, rats with lactic acidosis given
sodium bicarbonate intravenously were hyperventilated to
prevent CO2 accumulation; the concomitant hyperventilation
led to an increase in cardiac contractility that paralleled the
improvement in acid-base balance (Halperin and Kamel, 2010;
Kimmoun et al., 2014). The results of studies using THAM or
hyperventilation to minimize CO2 accumulation highlight the
benefits of minimizing CO2 generation during the buffering
process (Kallet et al., 2000).
In the 1980’s, an alternative approach was developed,
involving use of a mixed-base solution having fixed 1:1 molar
carbonate ratio of 333mM disodium carbonate (Na2CO3), a
strong base, and 333 mM sodium bicarbonate, yielding a
1.67M total osmolyte concentration (Filley and Kindig, 1985;
Bersin and Arieff, 1988). Termed “Carbicarb,” this solution was
introduced because of its potential to raise pH while at the
same time inhibiting significant generation of CO2. Carbicarb
(measured pH = 9.6) was significantly more basic than sodium
bicarbonate, yet it was still very hypertonic. While not explained
so directly in the original publications, compared to our simple
explanation below, introducing disodium carbonate into the
base’s composition can reduce dissolved CO2 levels. A divalent
carbonate anion CO2−3 can readily react with a hydronium ion
(H3O
+) in a partial neutralization reaction, yielding HCO−3 and
a water molecule. Alternatively, CO2−3 can react with a water
molecule (i.e., via hydrolysis), yielding a bicarbonate ion and a
hydroxide ion (OH−). This generated hydroxide ion, in turn,
can react with a dissolved CO2 molecule, thereby consuming
it and producing a bicarbonate ion. Thus, the addition of
CO2−3 to a neutral or acidic solution containing dissolved
CO2 leads to the net production of bicarbonate ions and the
net consumption of CO2. Moreover, our explanation of the
fundamental mechanism for this effect is general and suggests
that any strong base, which is capable of generating hydroxide
ions at sufficiently high concentrations, could potentially be used
to reduce dissolved CO2 levels. Obviously, anions of strong bases
also have the potential to participate in other reactions, including
deprotonating proteins, lipids, and other molecules that they
encounter, thereby causing undesirable caustic damage to tissues,
so ideally such highly reactive anions would be confined to
react only with small and very simple molecules and ions,
but not larger structures in the blood, vasculature, and other
tissues.
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Subsequent in vitro experiments, in which Carbicarb or
sodium bicarbonate was added to acidified blood in a closed
system (so as to identify production of CO2), revealed that
addition of sodium bicarbonate increased PCO2, whereas the
addition of Carbicarb led to little or no increase in PCO2
(Shapiro et al., 1995). In vivo studies in animals which have acute
lactic acidosis revealed that Carbicarb improved systemic acid-
base parameters, raised intracellular pH and improved cardiac
function, whereas sodium bicarbonate did not improve cardiac
function or improve intracellular pH (Bersin and Arieff, 1988).
By contrast, Carbicarb, when administered to humans who had
mild metabolic acidosis (serum [HCO−3 ] ≈ 20mEq/L) failed to
provide more benefit than sodium bicarbonate (Leung et al.,
1994). Although, this human study had a very limited scope, as
a consequence of this result, Carbicarb was never adopted in
clinical practice. However, because Carbicarb was reported to
be effective in the treatment of acute acidosis in limited animal
studies, we postulate that other mixed base solutions at reduced
osmolarity compared to Carbicarb, might also be effective and
deserve consideration.
The cellular dysfunction of acute acidosis, whether it be
metabolic or respiratory in origin, is related to reductions in the
intracellular and interstitial pH of vital tissues, primarily that
of the myocardium (Huang et al., 1995; Vaughan-Jones et al.,
2009; Schroeder et al., 2010). The failure of sodium bicarbonate
to improve cellular dysfunction is directly related to its inability
to consistently improve the acid-basemilieu of the compartments
(Kraut andMadias, 2012). Indeed, in several experimental studies
it has been shown to exacerbate the acidosis (Kindig and Filley,
1983; Levraut et al., 1996; Forsythe and Schmidt, 2000). So, in
light of these studies, it therefore seems reasonable to postulate
that development of alternative base solutions, tailored for the
treatment of specific types and severities of acute acidoses,
could potentially reduce acidification of vital tissues and improve
cellular function.
In the present paper, we present theoretical calculations of the
physical properties of mixed base solutions containing different
proportions of weak and strong bases. These results lead us to
introduce the concept of reduced osmolarity mixed base (ROMB)
solutions. ROMB solutions can contain a greater proportion of a
strong base than present in Carbicarb but at a lower osmolarity,
which reduces its potential for causing both caustic and osmotic
damage. At the same time, the higher proportion of the strong
base (e.g., 3:1 strong:weak) offers the advantage of consuming
more CO2, on a per molar basis of administered solution, than
simple 1:1 Carbicarb.
As a preliminary exploration of this hypothesis, we have tested
the ability of ROMB solutions to improve the acid-base balance of
acidified canine blood by adding one of a variety of base solutions
to determine their impact on plasma bicarbonate, blood pH, and
PCO2. Overall, a ROMB solution having a 3:1 ratio of Na2CO3:
NaHCO3 performs well in raising plasma pH and [HCO
−
3 ]
while reducing PCO2. Interestingly, ROMB solutions of sodium
hydroxide NaOH with NaHCO3 also offer a similar ability to
raise plasma pH and [HCO−3 ] while reducing PCO2 and lowering
the sodium load. Thus, ROMB solutions appear to be worthy
of further attention for in vivo testing as possible alternative
bases for the treatment of acute acidoses. Future studies will be
necessary to determine if such compositions suggested by these
in silico and in vitro results will lead to improved outcomes in
animals and humans.
MATERIALS AND METHODS
Modeling and Computation of Chemical
Properties of Mixed-Base Solutions
Aqueous Solutions of Sodium Bicarbonate and
Disodium Carbonate
We solve for the equilibrium concentrations of ionic species in
water after the addition of sodium bicarbonate and disodium
carbonate using the full, exact set of equilibrium equations that
include charge neutrality. This approach leads to a set of four
equations and four unknowns, which can be solved by finding the
appropriate zero of a quartic polynomial; we numerically solve
this quartic equation using Mathematica (Wolfram Research
Inc.).
When sodium bicarbonate NaHCO3 is dissolved in neutral
water, it dissociates:
NaHCO3(s)→ Na
+(aq)+HCO−3 (aq).
The initial concentration of the bicarbonate anion HCO−3 is
given by y0 = [HCO
−
3 ]0. When disodium carbonate Na2CO3 is
dissolved in neutral water, it also dissociates:
Na2CO3(s)→ 2Na
+(aq)+ CO2−3 (aq).
The initial concentration of the carbonate anion CO2−3 is given
by z0 = [CO
2−
3 ]0. Conservation of matter requires that the initial
concentration of sodium [Na+]0 is:
[Na+]0 = [HCO
−
3 ]0 + 2[CO
2−
3 ]0.
Since Na+ is ineffective in acid-base chemistry, the equilibrium
concentration of Na+ is:
[Na+] = [Na+]0 = [HCO
−
3 ]0 + 2[CO
2−
3 ]0.
Given [HCO−3 ]0 and [CO
2−
3 ]0 through the amounts of sodium
bicarbonate and disodium carbonate added to neutral water,
which has h0 = [H3O
+]0 = 10
−7 M, we set up a set of
simultaneous equations and solve for the equilibrium pH and
concentrations of the various ionic species.
The hydronium ion concentration at equilibrium is defined to
be h = [H3O
+], where Kw = 10
−14 is the equilibrium constant
associated with water auto-ionization, and [H3O
+][OH−] =
Kw, so [OH
−] = Kw/h. To simplify notation, we assign the
following variables to represent the equilibrium concentrations
of the carbonate species: x = [H2CO3], y = [HCO
−
3 ], and
z = [CO2−3 ]. We assume that no carbonic acid is present
initially, so we set x0 = [H2CO3]0 = 0. We write equations
for conservation of matter of the carbonate species, for charge
neutrality, and for the deprotonation reactions of carbonic
acid and the bicarbonate anion, respectively. Conservation of
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carbonate species at equilibrium means [HCO−3 ]0 + [CO
2−
3 ]0 =
[HCO−3 ]+ [H2CO3]+ [CO
2−
3 ], so,
x = (y0 − y)+ (z0 − z). (1)
Charge neutrality at equilibrium yields: [Na+] + [H3O
+] =
[HCO−3 ]+ 2[CO
2−
3 ]+ [OH
−], so:
(Kw/h)− h = (y0 − y)+ 2(z0 − z). (2)
Deprotonation of carbonic acid proceeds according to the
following equilibrium reaction:
H2CO3(aq)+H2O(l)↔ H3O
+(aq)+HCO−3 (aq).
The law of mass action requires Ka1 = [H3O
+] [HCO−3 ]
/[H2CO3]= 4.3× 10
−7, so:
Ka1 = hy/x. (3)
Deprotonation of the bicarbonate anion proceeds according to:
HCO−3 (aq)+H2O(l)↔ H3O
+(aq)+ CO2−3 (aq)
The law of mass action requires Ka2 = [H3O
+] [CO2−3 ]/[HCO
−
3 ]
= 4.8× 10−11, so:
Ka2 = hz/y. (4)
In this calculation, we use Ka1 = 4.3 × 10
−7 for carbonic acid
deprotonation, which effectively incorporates the equilibrium
between dissolved CO2 and H2CO3, and Ka2 = 4.8 × 10
−11 for
deprotonation of the bicarbonate anion at room temperature.
Thus, if all initial conditions are specified, Equations (1–4),
contain four unknowns h, x, y, and z, and these equations can
be solved exactly to provide equilibrium concentrations. We can
rewrite Equation 3 as x = hy/Ka1 and Equation 4 as z = Ka2y/h.
Substituting these relationships into Equation (1) yields:
hy/Ka1 = (y0 − y)+ [z0 − (Ka2 y/h)],
which can be solved to obtain y in terms of h:
y = (y0 + z0)/[1+ (h/Ka1)+ (Ka2/h)]. (5)
Substituting relationships for z into Equation (2) yields:
(Kw/h)− h = (y0 − y)+ 2(z0 − Ka2 y/h)
which can also be solved to obtain y in terms of h:
y = [y0 + 2z0 + h− (Kw/h)]/[1+ (2Ka2/h)]. (6)
The right hand sides of Equations (5) and (6) for ymust be equal
to ensure self-consistency, so:
[1+ (2Ka2/h)](y0 + z0) = [1+ (h/Ka1)+ (Ka2/h)][y0 + 2z0
+ h− (Kw/h)].
Expanding and collecting terms having different powers of
h yields a 4th order (i.e., quartic) polynomial in h, which
simplifies to:
h4/Ka1 + [1+ (y0 + 2z0)/Ka1]h
3
+ [Ka2 − (Kw/Ka1)+ z0]h
2
− (Kw + Ka2 y0)h− (Ka2 Kw) = 0. (7)
Although somewhat complex, quartic equations can be solved.
From among the four roots, which can include imaginary
numbers, we select the physical solution of Equation 7 for a
unique value of h = [H3O
+] that is positive and real. Other
imaginary or negative solutions are discarded. Once h is known,
y, x, and z can also be calculated. Using nested loops in
the Mathematica program, we calculate a set of equilibrium
results for a variety of initial concentrations of NaHCO3 and
Na2CO3. In the calculations, we designate the total carbonate
concentration to be Ctot = [HCO
−
3 ]0 + [CO
2−
3 ]0 and we
designate the initial ratio of bicarbonate to carbonate ions to be
R = [HCO−3 ]0/[CO
2−
3 ]0. Our calculations assume ideal activities
for the ionic species even at larger concentrations, so they should
be taken as a guide for revealing trends, and we would not
necessarily expect these calculated values to match experimental
values exactly as the solutions become more concentrated and
non-ideal activities play more important roles.
The value of x calculated in the previous equations actually
accounts for the sum of the dissolved carbonic acid plus dissolved
carbon dioxide, so we define [H2CO3]calc = x (combined). To
separate out the contributions to the different neutral species,
CO2(aq) and H2CO3(aq), it is necessary to consider the so-called
“hydration” equilibrium reaction of CO2 in water:
CO2(aq)+H2O(l)↔ H2CO3(aq).
The law of mass action requires Khyd = [H2CO3]act/[CO2]act,
where Khyd = 1.7 × 10
−3 at room temperature, [CO2]act is the
actual concentration of CO2 in the solution, and [H2CO3]act is
the actual concentration of H2CO3 in the solution. Since
x = [H2CO3]calc = [H2CO3]act + [CO2]act, (8)
we solve for [CO2]act = [H2CO3]calc/(1+ Khyd) and [H2CO3]act
= [H2CO3]calc − [CO2]act.
Once [CO2]act has been determined then Henry’s Law can be
used to calculate the partial pressure of CO2, commonly known
as PCO2:
PCO2 = KH[CO2]act, (9)
where KH = 2.23× 10
4 mmHg/M is Henry’s Law value for CO2
in H2O at room temperature. Pressures are then conveniently
expressed in the typical format of mm Hg when [CO2]act is
specified in molar units.
Aqueous Solutions of Sodium Bicarbonate and
Sodium Hydroxide
A certain amount of sodium bicarbonate is added to neutral
water, yielding an initial concentration of the bicarbonate anion
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[HCO−3 ]0 = y0. A certain amount of sodium hydroxide is added
to the same solution, yielding an initial concentration of the
hydroxide anion [OH−]0 = b0, where we assume that b0 =
[OH−]0≫ 10
−7 M(i.e., the concentration of hydroxide anions in
neutral water). The initial concentrations of the carbonate anion
and carbonic acid are also zero: x0 = [H2CO3]0 = 0 and z0
= [CO2−3 ]0 = 0. The sodium bicarbonate dissociates in water
as described previously, and the sodium hydroxide dissociates
according to:
NaOH(s)→ Na+(aq)+OH−(aq).
The initial concentration of the sodium cation is: [Na+]0 =
[HCO−3 ]0 + [OH
−]0 = y0 + b0. Since sodium is ineffective in
acid-base chemistry, the equilibrium concentration of the sodium
cation is simply the initial concentration: [Na+] = [Na+]0 =
y0 + b0. Conservation of carbonate species requires: [HCO
−
3 ]0
= [H2CO3]+ [HCO
−
3 ]+ [CO
2−
3 ], so:
y0 = x+ y+ z. (10)
Charge neutrality requires: [Na+] + [H3O
+] = [HCO−3 ] +
2[CO2−3 ]+ [OH
−], implying:
(Kw/h)− h = b0 + y0 − y− 2z. (11)
For the two reactions describing the carbonate equilibria, the
respective laws of mass action are given by Equations (3) and
(4). Substituting these equations into Equation (10) for the
conservation of carbonate species yields:
y = y0/[1+ (h/Ka1)+ (Ka2/h)], (12)
and into Equation 11 for the charge neutrality equation yields:
y = [y0 + b0 + h− (Kw/h)]/(1+ 2Ka2/h). (13)
Self-consistency requires that both expressions for y in terms of h
must be equal, so:
[y0 + b0 + h− (Kw/h)][1+ (h/Ka1) + (Ka2/h)]
= y0(1+ 2Ka2/h).
From this, we obtain a different quartic equation in the
hydronium ion concentration valid for mixtures of the weak base,
NaHCO3, with the strong base, NaOH:
[h2 + h(y0 + b0) − Kw][(h
2/Ka1)+ h+ Ka2]
− y0(h
2
+ 2Ka2h) = 0. (14)
We solve this quartic equation using Mathematica for various
initial concentrations of sodium bicarbonate, y0, and sodium
hydroxide, b0. Using the positive real values of h for the
solution, which provides the equilibrium [H3O
+], we obtain the
equilibrium concentrations y = [HCO−3 ] using Equation (12), z
= [CO2−3 ] using Equation (4), and x = [H2CO3] using Equation
(3). Using the CO2 hydration equilibrium reaction and Henry’s
law in Equations (8) and (9), respectively, we then calculate the
equilibrium carbon dioxide pressure PCO2 from [CO2]act.
Experimental Materials and Methods
Acidification of Canine Blood
Canine blood was obtained from Animal Blood Resources
International (Dixon, CA) and stored at 4◦C. Prior to shipment,
this blood was treated by the supplier with a citric anticoagulant
(CA) (Hess, 2006), citric phosphate dextrose adenine CPDA-1,
at a ratio of about 1 part CPDA-1 solution to 9 parts blood.
Consequently, this CA-treated blood was pre-acidified when
received. Because blood ages during storage, we label blood
samples used on different dates, well within the supplier’s use-
by date, and measure their baseline blood-gas parameters, which
can change over time. We label a first CA-treated blood sample
having a measured pH = 6.98 as CA-K9-1 and a second older
CA-treated blood sample having a measured pH = 6.90, slightly
more acidic, as CA-K9-2. Subsequently, a third CA-treated blood
sample, CA-K9-3, was obtained fresh from the supplier; its
measured pH = 7.00 is very close to that of the first fresh blood
sample. For some experiments, to keep BGA parameters of base-
treated acidified blood within the measurement range of our
BGA instrument, we have further treated the canine blood to
make it more acidic using an aqueous solution of hydrochloric
acid (HCl). Sample HCl-CA-K9-2, having a measured pH =
6.62, was made by mixing 1 part of a 150mM solution of HCl
with 9 parts of CA-K9-2, and sample HCl-CA-K9-3, having a
similar measured pH= 6.66, was obtained in the same way using
CA-K9-3.
Measuring pH and Blood-Gas Parameters of Blood
and Blood-Base Mixtures
To measure how new types of ROMB solutions affect blood
chemistry and to identify their compositions and concentrations
that could be suitable for treating acute acidosis, we have designed
and carried out experiments using canine blood that has been
pre-acidified using a citric anticoagulant. The primary blood
chemistry tests have been carried out using an IDEXX VetStat
Blood Gas Analyzer (BGA) and single-use IDEXX Electrolyte 8+
cassettes. The VetStat BGA has been calibrated using all standard
reference cassettes, passing the necessary reference tests, and it
was also calibrated using Levels 1, 2, and 3 OptiCheck fluids,
passing all calibration fluid tests successfully, thereby ensuring
accuracy of our subsequent measurements. The BGA directly
measures pH and PCO2 and uses these values to determine the
concentration of the bicarbonate ion [HCO−3 ]. The pH range of
the BGA has a lower limit of≈6.4 and an upper limit of≈7.8, and
the PCO2 has a lower limit of≈10mmHg. The BGA also directly
measures [Na+], [K+], and [Cl−]. All BGA measurements have
been made at a temperature T = 37◦C. When mixing, we used
glass containers, syringes, and capillaries as well as stainless steel
needles. The residence time was short enough and transfer to the
VetStat BGA device rapid enough that CO2 diffusion out of the
mixture was not significant (i.e., our measurements are effectively
performed in the closed system limit). After calibration, replicate
testing of the BGA instrument’s precision on separate samples
of CA-treated blood gave the following measured absolute and
percent standard deviations: pH = ±0.05 (± 0.8%), PCO2 =
±7.6mm Hg (±9.7%), [HCO−3 ] = ±0.4mM (±2.5%), [Na
+]
= ±1.1mM (±0.8%), [K+] = ±0.5mM (±12.9%), and [Cl−] =
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±1.7mM (±1.7%). These small uncertainties were obtained after
three trials, indicating the high precision of the BGA.
In addition, some pH-titration measurements have been
made using an Accumet pH meter equipped with an electrode
probe, suitable for small volumes, connected to a computer.
For titrations made using the pH meter, the volume dispense
rate of the base solution has been controlled using a computer-
controlled syringe-pump dispenser and a stir bar is used to mix
the added solution with the blood.
Acidified blood samples were treated with different base
solutions by adding 1 part of the base solution (e.g., 100 µL)
to 9 parts of acidified canine blood (e.g., 900 µL) and mildly
agitating for 10–20 s. The base-treated blood was then injected
using a syringe into a heparin-treated capillary tube of 200
microliter capacity. The capillary tube was inserted into the
aspiration nozzle of the Electrolyte 8+ cassette of the VetStat
BGA, and the BGA then tested the blood sample and recorded
the results. For each mixture, the entire procedure took less than
5 minutes from mixing to loading of the BGA. These conditions
effectively yielded BGA results for a passive closed system in
which active processes, such as respiration, were absent. A small
amount of the base-treated blood was transferred onto a heparin-
treated glass slide with a No. 1 coverslip for viewing using the
optical microscope. Into some base solutions that have lower ion
concentrations, we added sodium chloride, NaCl, in order to raise
their osmolarities without affecting pH.
Optical Microscopy of Acidified Blood and Treated
Blood
Optical microscopy was performed with a National Optical
brightfield microscope using a 40× objective and a digital camera
(Flea2 by Point Grey Research). The mixtures of solutions and
treated blood were made in low-flow conditions; harsh high-
flow mixing methods were purposefully avoided so changes in
observed structures could be primarily associated with different
solution chemistries. The image size (i.e., distance scale) has
been calibrated using a 100 line-per-mm reticle. Simple pH
measurements using the pH meter and optical microscope were
carried out at room temperature T ≈ 23◦C. Real-time blood
titration experiments have been performed with an automated
Hamilton syringe delivery system using the Accumet pH meter,
controlled by custom-written LabVIEW software.
RESULTS
Computer Calculations of Properties of
Mixed-Base Solutions
We solve for the equilibrium pH and ion concentrations in
a basic aqueous solution after dissolving known quantities of
sodium bicarbonate and of disodium carbonate into neutral
water (see Materials and Methods). The predicted equilibrium
pH values for a NaHCO3: Na2CO3 base solution at a 0.15M
fixed total carbonate concentration Ctot = [HCO
−
3 ]0 + [CO
2−
3 ]0
for different ratios of initial [CO2−3 ]0/[HCO
−
3 ]0 are shown in
Figure 1A. Here, we have chosen Ctot = 0.15M to be much
lower than Carbicarb, which has Ctot = 0.667M, so the resulting
ROMB solution would reduce the potential for adverse osmotic
FIGURE 1 | Predicted equilibrium properties of reduced osmolarity
mixed-base (ROMB) solutions composed of NaHCO3 and Na2CO3.
(A) pH and (B) PCO2 as a function of the ratio of the initial concentration of
carbonate anions [CO2−3 ]0 to the initial concentration of bicarbonate anions
[HCO−3 ]0, where the total concentration of carbonate species has been fixed
at 150mM. Gray squares mark the idealized predicted values of pH ≈ 10.8
and PCO2 ≈ 0.03mm Hg for a 3:1 Na2CO3: NaHCO3 ROMB solution.
effects on blood cells. In the limit of small [CO2−3 ]0/[HCO
−
3 ]0,
corresponding to a nearly pure sodium bicarbonate solution, the
resulting predicted pH ≈ 8.4 agrees well with the known value
of this weak base (Oxtoby et al., 2012). As a greater proportion
of Na2CO3 is used in the mixture, the pH increases until it
saturates near ≈ 11.7, corresponding to a nearly pure disodium
carbonate solution. In Figure 1B, the corresponding results for
PCO2 at Ctot = 0.15M are shown over a wide range of mixing
ratios. As a greater proportion of the strong base Na2CO3 is
used in the mixture, PCO2 is significantly reduced. So, one
may infer that mixed-base solutions made using more Na2CO3
would tend to reduce PCO2 levels if administered. Although,
the 0.15M solution has a reduced osmolarity compared to
sodium bicarbonate and Carbicarb, it is possible to achieve
about the same pH-raising capacity as a standard treatment
solution of 1.0 M sodium bicarbonate for the 3:1 mixture having
[CO2−3 ]0/[HCO
−
3 ]0 ≈ 3. This 3:1 mixture can be made by mixing
3 parts of 150mM Na2CO3 solution with 1 part of 150mM
NaHCO3 solution, yielding [CO
2−
3 ]0 = 112.5mM and [HCO
−
3 ]0
= 37.5mM, and a total osmolarity of about 412.5mM, including
sodium ions.
We have also calculated equilibrium values of pH and
PCO2 for 150mM mixed-base solutions that are made using
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NaHCO3 and NaOH for different ratios of initial concentrations
[OH−]0/[HCO
−
3 ]0 (see Materials and Methods), as shown in
Figures 2A,B, respectively. Although the trends are similar to
what has been shown in Figure 1, the use of sodium hydroxide
can further reduce PCO2 while providing an even larger increase
in pH and also keeping the final equilibrium [Na+] lower than
for corresponding mixtures of sodium bicarbonate and disodium
carbonate. Thus, theory predicts that the using other types
of strong bases, not just disodium carbonate, in mixed-base
solutions could potentially be useful for custom-tailoring the base
solution to treat different types of acute acidoses.
Blood Gas and pH Analysis of Acidified
Blood Treated by Mixed-Base Solutions
Experimental results of BGA measurements of solutions that
have been mixed with acidified canine blood samples yield
responses as a function of types, concentrations, and relative
proportions of species (see Tables 1–6). For instance, sodium
bicarbonate raises pH relatively little compared to strong bases
at similar molarity, yet it also elevates PCO2 substantially, which
is typically undesirable in treatment. By contrast, base-treatment
solutions of strong bases, such as Na2CO3 and NaOH, raise pH
by about 0.5 pH units. We find that Na2CO3 is highly effective
FIGURE 2 | Predicted equilibrium properties of ROMB solutions
composed of NaHCO3 and NaOH. (A) pH and (B) PCO2 of ROMB
solutions resulting from mixing different proportions of a 150mM NaOH
solution to a 150mM NaHCO3 solution, expressed by the ratio of the initial
concentration of hydroxide ions [OH−]0 divided by the initial concentration of
bicarbonate anions [HCO−3 ]0. The total initial concentration of basic species is
fixed at 150mM. For ratios greater than 1, PCO2 has a vanishingly small value
and is not shown.
in raising pH and [HCO−3 ] while lowering PCO2 substantially.
Similarly, NaOH, which is a strong base yet contains no carbonate
species, is also highly effective in raising pH. Moreover, 150mM
NaOH solution lowers PCO2 even more than the same molarity
solution of Na2CO3. Thus, solutions containing NaOH could
potentially be used instead of those containing Na2CO3 in certain
situations to control or reduce PCO2 if desired. We also find
that a ROMB solution composed of 75mM Na2CO3 + 75mM
NaOH, which has 150mM total of strong base species, raises pH
by about the same amount as either 150mM pure Na2CO3 or
150mM pure NaOH solutions, yet results in values of PCO2 and
[HCO−3 ] that are intermediate between those of the two pure base
solutions. Thus, by adjusting the proportion of two strong bases,
Na2CO3 and NaOH, in a ROMB solution, it is possible to control
plasma [HCO−3 ] in a desirable range while increasing plasma pH
and decreasing PCO2.
Figure 3 shows BGA results for pH, PCO2, [HCO
−
3 ], and
[Na+] after three different 150mM strong-base solutions,
containing disodium carbonate and sodium hydroxide in
TABLE 1 | Responses of CA acidified canine blood to added solutions.
Added Conc. pH PCO2 [HCO
−
3
] [Na+] [K+] [Cl−]
solution (mM) (mm Hg) (mM) (mM) (mM) (mM)
None 0 6.90 87 15.8 148 4.2 98
Na2CO3 150 7.57 43 37.1 164 3.4 103
NaOH 150 7.47 23 15.3 147 3.6 98
Na2CO3 +
NaOH (1:1)
75 + 75
= 150 tot
7.47 36 24.0 156 3.5 100
HCl 150 6.62 113 10.8 128 3.8 94
(1 part solution: 9 parts CA-K9-3)
None 0 7.00 73 16.6 150 3.3 101
NaOH
NaCl
150
75
7.54 21 16.4 155 2.9 105
Tris soln 150 7.50 27 19.5 135 2.9 98
Tris soln
NaCl
150
75
7.50 26 19.1 144 2.9 104
Tris buffer 150 7.18 41 14.4 134 3.0 100
(1 part solution: 9 parts CA-K9-2): see Figure 3 for plot of added strong base solutions.
Two-component solutions are designated by a non-indented first component and an
indented second component in the column under Added solution.
TABLE 2 | Responses of HCl-CA acidified canine blood to added base
solutions.
Added base
solution
Conc. pH PCO2 [HCO
−
3
] [Na+] [K+] [Cl−]
(mM) (mm Hg) (mM) (mM) (mM) (mM)
None 0 6.62 113 10.8 128 3.8 94
NaHCO3 150 6.82 141 21.2 135 3.1 92
Na2CO3 150 7.31 61 28.4 153 3.0 98
NaOH 150 7.21 23 8.3 135 3.2 95
Na2CO3 +
NaOH (1:1)
75 + 75
= 150 tot
7.37 28 15.3 143 3.1 97
(1 part solution: 9 parts HCl-CA-K9-2): see Figure 4 for plot of added strong base
solutions.
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TABLE 3 | Responses of HCl-CA acidified canine blood to added base
solutions: concentration dependence at fixed 1:1 mixing ratio of NaHCO3
and Na2CO3.
Added
base
solution
Conc. pH PCO2 [HCO
−
3 ] [Na
+] [K+] [Cl−]
(mM) (mm Hg) (mM) (mM) (mM) (mM)
None 0 6.62 113 10.8 128 3.8 94
NaHCO3
Na2CO3
167
167
7.76 38 50.5 171 2.7 106
NaHCO3
Na2CO3
333
333
8.36 13 − − 2.6 118
(1 part solution: 9 parts HCl-CA-K9-2): see also Figure 5 for corresponding plot.
A pH value in italics represents a non-BGA electrode measurement.
Dashes indicate values outside of the instrumental range of the BGA.
TABLE 4 | Responses of CA-acidified canine blood to added base
solutions: dependence on mixing ratio of NaHCO3 and Na2CO3 at fixed
150mM carbonate concentration.
Added
base
solution
Conc. pH PCO2 [HCO
−
3 ] [Na
+] [K+] [Cl−]
(mM) (mm Hg) (mM) (mM) (mM) (mM)
None 0 6.98 75 16.4 148 3.5 98
NaHCO3
Na2CO3
0
150
7.54 44 34.7 162 2.8 103
NaHCO3
Na2CO3
25
125
7.50 47 34.3 162 2.8 102
NaHCO3
Na2CO3
37.5
112.5
7.54 47 36.9 162 2.8 101
NaHCO3
Na2CO3
75
75
7.41 57 33.6 158 2.9 99
(1 part solution: 9 parts CA-K9-1).
different proportions but fixed molarity (150mM Na2CO3 only,
1 part 150 mM NaOH mixed with 1 part 150 mM Na2CO3,
and 150mM NaOH only), were added to CA-treated canine
blood (CA-K9-2). We use the dimensionless mole fraction of
NaOH, xNaOH, in the strong-base mixture as a quantitative
identification. All three strong-base solutions provide about the
same increase in pH of the CA-treated blood, since both strong
bases generate about the same concentration of hydroxide ions
and the overall molarity of strong-base species has been fixed
at 150mM, regardless of xNaOH. We calculate the average pH =
7.50 ± 0.06 of the base-treated blood (solid line in Figure 3A),
so the increase in pH caused by the strong base treatment from
the reference level (dashed line) is1pH= 0.60± 0.06. However,
PCO2 is more substantially reduced by using a base solution that
contains more NaOH than Na2CO3. A linear least squares fit
of the results for PCO2 in Figure 3B yields a slope of −0.20 ±
0.03 mm Hg/%xNaOH and an intercept of 44.0 ± 2.2 mM Hg
at xNaOH = 0% (correlation coefficient R = 0.985). Likewise,
a linear fit of [HCO−3 ] in Figure 3C yields a slope of −0.22
± 0.03 mM/%xNaOH and an intercept of 36.4 ± 1.6mM (R =
0.993). While NaOH provides essentially the same pH increase
as Na2CO3, the equilibrium sodium ion concentration in the
treated blood is lower for NaOH than for Na2CO2 because NaOH
TABLE 5 | Responses of HCl-CA acidified canine blood to added base
solutions: dependence on mixing ratio of NaHCO3 and Na2CO3 at fixed
150mM carbonate concentration.
Added
solution
Conc. pH PCO2 [HCO
−
3
] [Na+] [K+] [Cl−]
(mM) (mm Hg) (mM) (mM) (mM) (mM)
None 0 6.66 115 11.9 130 3.0 95
Na2CO3 150 7.39 47 26.2 152 2.5 99
NaHCO3
Na2CO3
25
125
7.31 60 27.4 152 3.6 99
NaHCO3
Na2CO3
37.5
112.5
7.20 73 26.4 150 4.3 99
NaHCO3
Na2CO3
75
75
7.04 101 25.2 145 5.6 98
NaHCO3 150 6.86 135 22.6 136 2.6 93
NaOH
NaCl
150
75
7.33 21 10.1 143 2.6 100
Tris soln
NaCl
150
75
7.24 28 11.0 131 2.6 100
Tris buffer 150 6.96 42 8.8 122 2.7 98
(1 part solution: 9 parts HCl-CA-K9-3): see also Figure 7 for plot of top panel.
Lower panel: responses caused by adding other non-carbonate base solutions.
TABLE 6 | Measured pH of base solutions.
Base solution Measured pH
150mM NaHCO3 8.18
1.0M NaHCO3 8.10
75mM Na2CO3 11.18
100mM Na2CO3 11.33
150mM Na2CO3 11.42
200mM Na2CO3 11.35
250mM Na2CO3 11.35
360mM Na2CO3 11.37
1.0M Na2CO3 11.66
100mM NaOH + 100mM NaCl 12.91
150mM NaOH 12.95
75mM Na2CO3 + 75mM NaOH 12.64
150mM Tris + 75mM NaCl 10.08
150mM Tris Buffer 8.11
167mM NaHCO3 + 167mM Na2CO3 9.80
333mM NaHCO3 + 333mM Na2CO3 (i.e., Carbicarb) 9.63
25mM NaHCO3 + 125mM Na2CO3 10.48
37.5mM NaHCO3 + 112.5mM Na2CO3 10.23
is monovalent in sodium but Na2CO3 is divalent in sodium. A
linear least squares fit of the results for [Na+] in Figure 3D yields
a slope of−0.17± 0.01 mM/%xNaOH and an intercept of 164.2±
0.4mM (R= 0.999). All reported uncertainties are plus or minus
one-standard deviation; high values of R near unity indicate that
linear fits are appropriate for the observed trends.
In a related experiment for HCl-CA-treated blood, Figure 4
shows BGA results for pH, PCO2, [HCO
−
3 ], and [Na
+] after
150 mM strong-base solutions, containing NaOH only, Na2CO3
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FIGURE 3 | Response of acidified canine blood to ROMB solutions
composed of Na2CO3 and NaOH. Measured blood gas parameters (A) pH,
(B) PCO2, (C) [HCO
−
3 ], and (D) [Na
+] of citric acid (CA) acidified canine blood
CA-K9-2 as a function of xNaOH, the fraction of NaOH solution, in ROMB
solutions having different proportions of 150mM NaOH solution to 150mM
Na2CO3 solution. One part of the ROMB solution is added to nine parts of
acidified canine blood. Dashed lines represent parameter values of the
acidified canine blood prior to adding the ROMB solution. Solid line in (A) is
the average of the measured pH values; solid lines in (B–D) are linear least
squares fits (see text for parameter values and uncertainties).
only, and 50% NaOH mixed with 50% Na2CO3, were added to
HCl-CA-K9-2. The trends in the results with xNaOH are similar
to those in Figure 3, even though the starting pH of HCl-CA-
K9-2 is lower and its starting PCO2 is higher as a consequence
of the additional HCl-acidification of the CA-treated blood. In
Figure 4A, the average pH of the strong-base-treated acidified
blood is 7.30± 0.08, so the increase in pH as a result of treatment
with the strong base mixture is 1pH = 0.59 ± 0.08, comparable
to that in Figure 3A. A larger proportion of NaOH causes a
greater reduction in PCO2, which could be desirable in principle.
A linear least squares fit of the results for PCO2 in Figure 4B
FIGURE 4 | Response of HCl-acidified canine blood to ROMB solutions
composed of Na2CO3 and NaOH. Measured blood gas parameters (A) pH,
(B) PCO2, (C) [HCO
−
3 ], and (D) [Na
+] of HCl-CA-K9-2 acidified canine blood
as a function of xNaOH, the fraction of NaOH solution, in ROMB solutions
having different proportions of 150 mM NaOH solution to 150 mM Na2CO3
solution. One part of the mixed solution is added to nine parts of acidified
canine blood. Dashed lines represent parameter values of the acidified canine
blood prior to adding the ROMB solution. Solid line in (A) is the average of the
measured pH values; solid lines in (B–D) are linear least squares fits (see text
for parameter values and uncertainties).
yields a slope of −0.38 ± 0.16 mm Hg/%xNaOH and an intercept
of 56.0 ± 10 mM Hg at xNaOH = 0% (R = 0.920). Likewise,
a linear fit of [HCO−3 ] in Figure 4C yields a slope of −0.20
± 0.03 mM/%xNaOH and an intercept of 27.4 ± 2.3 mM (R
= 0.985). When pure NaOH is used, [HCO−3 ] drops below its
initial concentration, and this would typically be undesirable if
the initial bicarbonate ion concentration in the acidified blood is
already below the normal range. In Figure 4D, [Na+] decreases
linearly as more NaOH, which contains less sodium, replaces
Na2CO3 in the added solution. A linear least squares fit of
the results for [Na+] in Figure 4D yields a slope of −0.18 ±
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0.01mM/%xNaOH and an intercept of 152.7 ± 0.7mM (R =
0.998). The slopes of all of the decreasing trends in Figures 3B–D,
4B–D are similar, within the uncertainties, so the changes in
responses of the BGA parameters to the mixed strong-base
solutions are similar regardless of the degree of pre-acidification
of the blood. For HCl-CA-treated blood, a value of xNaOH =
20% yields desirable BGA values for pH, PCO2, [HCO
−
3 ], and
[Na+] in the treated blood that are all in the normal range. Thus,
by controlling the relative proportions of carbonate and non-
carbonate bases in a mixed base solution, it is possible to raise pH
in a similar manner to a desirable level, yet control the carbonate
parameters in the base-treated acidified blood independently so
as to achieve desirable levels of PCO2 and [HCO
−
3 ] also.
For reference, Figure 5 shows BGA results after mixing
equimolar 1:1 base-treatment solutions, which contain equal
proportions of the weak base NaHCO3 to the strong base
Na2CO3 but different total carbonate species concentrations,
with HCl-CA-K9-2 (9 parts acidified blood: 1 part base solution).
Reference values of the BGA parameters of the acidified canine
blood in the absence of base treatment correspond to points
at [Carbonate] = 0mM. The effects of Carbicarb treatment
are given by the points at a total carbonate concentration of
667mM (i.e., at the largest [Carbonate] shown). While we find
that the Carbicarb composition does raise pH and lower PCO2
considerably, it also raises [HCO−3 ] and [Na
+] dramatically,
and these effects could potentially be undesirable in treatment
applications, beyond concerns related to Carbicarb’s potential for
creating adverse hypertonic effects because of its high molarity.
BGA results are plotted in Figure 6 after adding disodium
carbonate base solutions at different concentrations to HCl-CA-
K9-2. Reference values of the BGA parameters of the acidified
canine blood in the absence of base treatment correspond to
points at [Na2CO3] = 0mM. The pH-response of the treated
blood to [Na2CO3] in the treatment solution is linear (R =
0.997); the slope from the least squares fit in Figure 6A is 5.0
± 0.2 pH unit/M and the intercept is at pH = 6.62 ± 0.03.
The addition of Na2CO3 also causes a significant reduction in
PCO2 while [HCO
−
3 ] rises. However, as a simple consequence
of stoichiometry, using Na2CO3 causes [Na
+] to rise with added
carbonate concentration twice as fast as an equivalent molarity
solution of NaHCO3. Consequently, [Na
+] rises out of the
normal range at the highest values shown. If only Na2CO3 is used
to treat HCl-CA-acidified canine blood, then the most optimal
concentration to bring all four BGA parameters shown into the
normal range is about 150 mM Na2CO3.
By contrast, Figure 7 shows BGA results after ROMB
solutions containing differing proportions of NaHCO3 to
Na2CO3, yet a fixed total added carbonate species concentration
of 150mM, were added to HCl-CA-K9-3. As the percentage of
Na2CO3 increases, the pH of the treated blood rises significantly
while PCO2 is lowered. Moreover, [HCO
−
3 ] can be kept in a
desirable range. Although there is an increase in [Na+], it is not as
extreme as with hypertonic base solutions such as 1.0 M sodium
bicarbonate or Carbicarb. In particular, a 3:1 ROMB solution,
made bymixing three parts 150mMNa2CO3 to one part 150mM
NaHCO3, offers a desirable increase in pH while reducing PCO2
and maintaining [HCO−3 ] and [Na
+] near the normal range.
FIGURE 5 | Response of HCl-acidified canine blood to 1:1 solutions
composed of NaHCO3 and Na2CO3. Measured blood gas parameters (A)
pH, (B) PCO2, (C) [HCO
−
3 ], and (D) [Na
+] of HCl-CA-K9-2 acidified canine
blood vs. concentration of carbonate species, [Carbonate], of equal volumes
of aqueous solutions of equimolar NaHCO3 and Na2CO3 (i.e., 1:1
proportions). One part of the mixed base solution is added to nine parts of
acidified canine blood. In each panel, the reference parameter value of
acidified blood without base treatment corresponds to the point at [Carbonate]
= 0 mM and the dashed line. Values for [HCO−3 ] and [Na
+] at the highest
concentration lie beyond the detection limits of the BGA.
To complement BGA measurements, we have also performed
separate titrations of acidified canine blood HCl-CA-K9-3 using
three different base solutions (150mM NaHCO3, 100mM
Na2CO3, and 100mM NaOH: 100mM NaCl) while measuring
pH using the pH meter, as shown in Figure 8. A volume Vb
of base solution is mixed with an initial volume of 4.0mL of
HCl-CA-acidified canine blood. The ROMB solutions containing
strong bases Na2CO3 and NaOH/NaCl yield nearly identical
titration curves for small added base volumes Vb ≤ 1mL. In this
case, relatively small volumes of these solutions, Vb ≈ 0.25mL,
raise pH into a desirable range to about 7.4; by contrast, a much
larger Vb ≈ 1.2mL of the base solution of the weak NaHCO3
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FIGURE 6 | Response of HCl-acidified canine blood to Na2CO3
solutions: concentration dependence. Measured blood gas parameters
(A) pH, (B) PCO2, (C) [HCO
−
3 ], and (D) [Na
+] of HCl-CA-K9-2 acidified canine
blood as a function of [Na2CO3] of added base solution. One part of disodium
carbonate solution is added to nine parts of acidified canine blood. In each
panel, the reference parameter value of acidified blood without base treatment
corresponds to the point at [Na2CO3] = 0mM and the dashed line. Solid line
in (A) is a linear least squares fit (see text).
is needed. Thus, ROMB solutions containing a large proportion
of a weak base would be significantly less effective in raising
pH of acidified blood. For the two strong base solutions shown,
interesting non-linear responses are seen at higher Vb, but such
large relative administration volumes would not be practical in
clinical applications.
Optical Microscopy of Blood Treated Using
Mixed-Base Solutions
We have also investigated the consequences of adding mixed-
base solutions to CA-treated blood using brightfield optical
transmission microscopy, which can reveal spiculation, lysis, and
FIGURE 7 | Response of HCl-acidified canine blood to ROMB solutions
composed of NaHCO3 and Na2CO3. Measured blood gas parameters (A)
pH, (B) PCO2, (C) [HCO
−
3 ], and (D) [Na
+] of HCl-CA-K9-3 acidified canine
blood as a function of xNa2CO3 , the fraction of Na2CO3 solution in a ROMB
solution made by mixing a 150 mM NaHCO3 solution with a 150mM Na2CO3
solution in different proportions. One part of ROMB solution is added to nine
parts of acidified canine blood. Values at xNa2CO3 = 75% correspond to the
3:1 ROMB solution. Dashed lines represent measured values for the acidified
canine blood prior to the addition of the ROMB solution.
rouleaux formation (Baskurt et al., 1997; Bäumler et al., 1999)
of red blood cells (RBCs). For reference, Figure 9A shows a
microscope image of CA-treated canine blood as received from
the supplier. The RBCs in fresh CA-treated blood have a normal
appearance (biconcave, diameter ≈ 7 µm). Consequently, CA-
treated blood serves as a useful reference point for optical
microscopy observations: any change in the structures of RBC’s
seen in CA-treated blood that has beenmixed with a base solution
are clearly a consequence of that particular base solution. Because
a significant percentage of RBCs in HCl-CA-treated blood exhibit
spiculation and rouleaux formation (see Figure 9F), which are
complex and possibly irreversible structural changes, even before
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FIGURE 8 | Titration of HCl-acidified canine blood by base solutions.
Measured pH during titration of an initial volume of 4mL of HCl-CA-K9-3
acidified canine blood using an added volume Vb of a base solution, 150 mM
NaHCO3 (squares), 100 mM Na2CO3 (circles), and 100mM NaOH + 100mM
NaCl (triangles); Dashed line, pH = 7.4 reference level, showing that nearly 5
times the volume of 150mM NaHCO3 would be needed compared to 100mM
Na2CO3 solution to raise the pH of the blood to the reference level. The
titration has been performed at 23◦C.
mixing with a base solution, HCl-CA-treated blood is less useful
as a starting point for determining structural changes caused by
base treatment through optical microscopy experiments. Thus,
our optical microscopy experiments focus primarily on mixtures
of CA-treated blood with base solutions.
Figure 9B shows an example of the appearance of 9 parts CA-
treated blood mixed with 1 part of a 1.0M NaHCO3 solution,
which is approved for use in medical practice to treat acute forms
of acidosis. The image shows that considerable damage can be
caused to RBCs, presumably by osmotic effects, as a result of
adding 1 part of hypertonic 1.0 M treatment solution to 9 parts
of blood and rapidly mixing it. Based on this finding, where
a 1.0M NaHCO3 solution first contacts the blood of a patient
(e.g., where the base solution exits the IV needle and enters the
blood), it is possible that at least some RBCs and other structures
in the blood would be damaged, even if a large population
would remain undamaged because of flow mixing and dilution
with the patient’s much larger blood volume. Thus, very rapid
IV administration of a hypertonic 1.0 M sodium bicarbonate
solution could cause some undesirable osmotic damage to blood
cells and create additional stress on an acidotic patient.
By contrast, Figure 9C shows an example of the appearance
of canine blood that has been treated with a solution of
150mM Na2CO3. The RBCs are clearly biconvex and are not
spiculated; they appear very similar to those in Figure 9A and
are essentially undamaged. This demonstrates that a reduced
osmolarity solution of a strong base, in this case disodium
carbonate, can be mixed into blood without causing visible
damage to RBCs. Thus, the strong base solution of 150mM
Na2CO3 does effectively raise pH and lower PCO2 in blood; plus,
it does not visibly damage RBCs. Figure 9D shows an example
of the appearance of canine blood that has been treated with a
reduced osmolarity solution of 150 mM NaOH. Relatively little
damage to RBCs is observed; a few (i.e., less than 10%) spiculated
RBCs are seen. However, rouleaux formation is evident. For
certain species of mammals, blood that has been removed and
not flowing is known to exhibit spontaneous rouleaux formation
(e.g., in equine blood) (Baskurt et al., 1997; Bäumler et al., 1999).
Thus, blood can still be functional and viable even if rouleaux are
seen. So, the observation of rouleaux formation of RBCs, while
not ideal, is of minor importance compared to changes in the
shape and integrity of RBCs.
Reducing the amount of NaOH and increasing the amount
of Na2CO3, yet keeping the total composition near isotonic
concentration, can reduce the rouleaux formation. Figure 9E
shows an example of the appearance of canine blood that has
been treated with a ROMB solution of 75 mM NaOH + 75 mM
Na2CO3, yielding a total concentration of strong base species of
150 mM (i.e., having a similar power to raise pH as solutions in
Figures 9C,D). Rouleaux formation is largely absent; only a few
very small aggregates are seen. Although a very small population
(i.e., less than 10%) of spiculated RBCs are observed, the vast
majority of RBCs are undamaged, similar to Figure 9C.
CA-treated canine blood that has been mixed with 150 mM
HCl (9 parts blood: 1 part HCl solution) is shown in Figure 9F.
A significant population (approximately 30%) of the RBCs
exhibit spiculation, and rouleaux are also observed. Because these
features are irreversible and could affect the interpretation of
microscope images of HCl-acidified blood that is subsequently
treated with base solutions, we do not show any images of
base-treated HCl-CA-acidified canine blood.
Figure 9G shows an optical micrograph of CA-acidified
canine blood that has been treated with Carbicarb. A large
fraction, nearing about 50%, of RBCs are damaged: noticeably
spiculated, deformed, or broken. Some smaller rouleaux are also
observed of the remaining biconcave fraction of RBCs. This
micrograph, combined with Figure 9B, provides evidence that
rapid injection of highly concentrated (i.e., very hypertonic) base
solutions is unlikely to be optimal when treating acute forms of
acidosis.
Acidified canine blood CA-K9-3, treated with a ROMB
solution of saline-supplemented sodium hydroxide (150 mM
NaOH+ 75 mMNaCl added in 1 part to 9 parts blood), is shown
in Figure 9H. Nearly all RBCs are normal and biconcave and very
few are spiculated. A few smaller rouleaux are present, but the
addition of a small saline concentration appears to reduce the
amount of spiculation and also rouleaux formation, compared to
150 mM NaOH only (see Figure 9C).
DISCUSSION
Our in silico study provides a fundamental basis for
understanding ROMB solutions, which could potentially be
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FIGURE 9 | Micrographs of acidified canine blood after mixing with solutions. Optical brightfield transmission micrographs of 9 parts CA-treated canine blood:
1 part solution. (A) CA-treated blood without any added solution (control), (B) 1.0 M NaHCO3, (C) 150 mM Na2CO3, (D) 150mM NaOH, (E) 75mM Na2CO3 + 75
mM NaOH, (F) 150 mM HCl, (G) 333mM NaHCO3 + 333 mM Na2CO3, (H) 150 mM NaOH + 75 mM NaCl.
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customized and used to treat different types of acute acidoses.
A key finding, in accord with thermodynamic principles, is that
reducing the overall osmolarity of a base solution while also
using a higher proportion of a strong base, can still be effective
in raising blood pH while lowering PCO2 and maintaining or
increasing blood [HCO−3 ] concentration. This higher proportion
of strong base produces hydroxide ions, ultimately consuming
carbonic acid and therefore reducing PCO2, by Le Chatelier’s
principle and Henry’s Law (Oxtoby et al., 2012). In addition,
our predictions show that in some circumstances strong
monosodium bases, such as NaOH, could potentially offer
an advantage over strong disodium bases, such as Na2CO3,
because monosodium bases reduce added [Na+]. Based on our
calculations, we hypothesize that the chemical composition
of a base solution could be customized and optimized for
individual acidotic patients according to the types and severities
of acidoses as well as the potential need for a reduced sodium
load. We expect that using non-ideal activities, rather than ideal
concentrations of species in these equations, such as are given
by the Debye-Hückel or Davies equations (Tissue, 2013), would
improve the accuracy of the calculated predictions but would not
affect the overall trends.
Our in vitro measurements indicate that ROMB solutions
that contain majority proportions of a strong base in their
compositions could be beneficial compared to conventional
hypertonic weak base solutions and other existing alternatives.
Optimizing the composition of a ROMB solution can be
performed with the goal of raising blood pH as well as that
of interstitial and intracellular compartments, lowering blood
and tissue CO2, and minimizing potential osmotic damage
to circulating blood elements. For instance, ROMB solutions
containing a higher proportion of a strong base, (e.g., 3:1
Na2CO3:NaHCO3), by contrast to hypertonic 1:1 Carbicarb,
appear to hold promise as efficacious treatment solutions
for certain types of acidosis. Through optical microscopy,
we have also demonstrated that hypertonic 1.0 M sodium
bicarbonate solution and hypertonic Carbicarb, if administered
rapidly, could potentially cause osmotic damage to blood cells.
By contrast, ROMB solutions, particularly those that have
an osmolarity closer to isotonic, perturb cellular structures
significantly less than such hypertonic solutions when mixed
rapidly. Thus, ROMB solutions such as 3:1 Na2CO3:NaHCO3
could potentially be used to advantage, compared to existing
hypertonic solutions, in situations where raising pH rapidly
without causing significant damage to beneficial components
in the blood is indicated. If a lower sodium load is desired,
then a certain fraction of Na2CO3 could be replaced by NaOH
in a ROMB mixture with NaHCO3, but this may need to
be moderated in consideration of the propensity of NaOH
to reduce [HCO−3 ] compared to Na2CO3. Beyond this, in
certain clinical situations, treatment to achieve a lower blood
pH range between about 7.2 and 7.3 can be desirable; in
such cases, using a ROMB solution that has a ratio lower
than 3:1 strong base:weak base (e.g., a 2:1 solution) could
potentially enable different desired lower pH targets to be
reachedwith reasonable injection volumes while further reducing
risk of possible caustic damage. Thus, through compositional
customization, ROMB solutions appear to offer some limited
but interesting potential for controlling pH as well as other
electrolyte and dissolved gas parameters into desired target
ranges simultaneously.
Future studies, performed both in vitro and in vivo, could
examine the impact of rate-controlled titrations of blood
using various base solutions and lead to additional insight
into how the composition and rate of administration of base
solutions can be tailored most beneficially for the treatment
of certain acid-base disorders. Regarding in vitro experiments,
investigating the effects of the history of microcirculation
and pH change on the structures of RBCs and rheology
of blood would be interesting to pursue. Regarding in vivo
experiments, optimizing ROMB solutions for the treatment of
animals with metabolic or respiratory acidosis could lead to
significantly improved outcomes. In such studies, it would be
desirable to measure intracellular pHi and extracellular pHe
in certain tissues, not just arterial blood pH. There might be
conditions for which administration of bicarbonate solutions
could raise the pH of cells rather than reduce it (Nielsen
et al., 2002). Also, the normal pH-regulatory proteins, including
the Na+-H+ exchanger, NHE1, will tend to improve cellular
acid-base balance even in the absence of administered base
restoring cellular pH to baseline. However, activation of this
transporter can cause deleterious increments in cellular sodium
and calcium and typically needs to be minimized (Wu and
Kraut, 2014). Thus, there are likely to be some situations in
which administration of simple bicarbonate solutions might be
sufficient without requiring the properties of a ROMB solution
that contains a high proportion of a strong base. Measuring
the deformability of RBCs as a function of pH (Kuzman
et al., 2000), by adjusting the composition and concentration of
added base solutions at different flow conditions, including in
microfluidic channels (Korin et al., 2007), would likely provide
a quantitative basis for understanding how to control and
alleviate local caustic and osmotic damage to RBCs and other
structures.
Indeed, it is highly unlikely that a single base solution would
be optimal for treating all of the many different types of acute
acidoses that are encountered clinically in a wide variety of
patients who have varied genetics and other co-existing medical
conditions. Our work on ROMB solutions instead suggests
that an optimal composition, concentration, and method of
administration of a base solution for a particular patient could
potentially be custom-tailored according to the severity and
nature of the patient’s acid-base parameters, his/her physiological
parameters, other co-existing medical conditions, and possibly
also, if known, genetics of important acid-base transporters and
other proteins. We emphasize that our in silico and in vitro
studies have not accounted for active processes, such as changes
in respiration, bicarbonate production, and acid production,
which in and of themselves can significantly affect the acid-base
milieu of tissues. Therefore, extending our theoretical modeling
to account for the influence of ROMB solutions on complex time-
dependent transport reactions in active open systems that mimic
organisms with circulation and respiration, as well as including
a broader range of ionic species, is a promising future direction.
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Such future predictive time-dependent models could incorporate
additional ionic complexity and organ-related sources and sinks
inherent in Stewart’s classic “strong ion difference” approach
(Stewart, 1983), including divalent cations and poly-electrolytic
proteins, as well as complex non-diffusive and diffusive transport.
In summary, from a clinical perspective, because measures
to eliminate the underlying cause of the acidosis are not always
successful, administration of base to improve the acid-base
parameters is often recommended. However, the most common
base administered, sodium bicarbonate, is often associated with
acidification of the intracellular compartment, even if it improves
systemic acid-base balance. Because this acidification can be a
consequence of the CO2 generated through the buffering process,
measures to improve acid-base balance without generating
CO2 would potentially be of great value. The only base
that is clinically available which can accomplish this task is
THAM. However, THAM has been associated with certain
adverse effects, and THAM requires intact renal function to
be effective. Our present studies have therefore examined the
impact that various strong bases and ROMB solutions can
have on pH, [HCO−3 ], and PCO2 when added in realistic
proportions to acidified blood. The results indicate that certain
base combinations can potentially improve acid-base balance and
actually reduce CO2 generation. These particular bases would
likely be most effective in treating patients with acute lactic
acidosis due to reduced tissue perfusion, a common cause (Kraut
and Madias, 2016). They could also be potentially useful in
treating patients with acute respiratory acidosis that have an
impaired ability to expel CO2 actively. Testing the viability of
ROMB solutions in the treatment of acidotic animals, which
could have different controlled types and severities, and then
eventually humans seems to be indicated based on promising
features of these solutions, as surmised from these initial
studies.
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